Pfizer says Canada has selected its "Abrysvo" RSV vaccine for use in adults 60 and over for the upcoming virus season. "Abrysvo" is also approved for use in pregnant people to provide protection to ...

By Lauren Pelley, CBC News, RCI Provinces taking different approaches, many Canadians may be paying out of pocket Respiratory syncytial virus, or RSV (new window), isn’t always top of mind during the ...

Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory ...

Arexvy is the clear leader in the RSV vaccine space, becoming the first approved shot in May 2023, a month ahead of its ...

RSV is a highly infectious virus that is the most common cause of respiratory infections in children. A free vaccine could soon be available to help prevent it.

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

With a new production line, Sanofi aims to keep it and partner AstraZeneca’s drug Beyfortus in fully supply this RSV season.

Given its better valuation, we believe that Pfizer stock (NYSE: PFE) is currently a better pick than its industry peer – AbbVie stock (NYSE:ABBV). PFE stock trades at a much lower multiple of 11x ...

Vaccines for the Fall and Winter 2024–2025 season are now available. Generally, experts recommend COVID-19 and flu vaccines ...

RSV, and flu viruses, the Dubois County Health Department (DCHD) is now offering all three vaccines on a daily basis. Covid-19- CDC recommends everyone 6 months and older get an updated COVID-19 ...